Skip to main content

Advertisement

Log in

Rates of Pre-exposure Prophylaxis Use and Discontinuation Among a Large U.S. National Sample of Sexual Minority Men and Adolescents

  • Special Section: Social And Behavioral Science With Gay And Bisexual Men In The Era Of Biomedical Prevention
  • Published:
Archives of Sexual Behavior Aims and scope Submit manuscript

Abstract

Pre-exposure prophylaxis (PrEP) is highly effective in the prevention of HIV acquisition and was recently approved for those under 18 years of age. The primary goal of the present study was to understand the prevalence of and factors associated with PrEP use among a large sample of young and adult sexual minority men (Y/SMM). Participants came from a larger national sample of SMM. Data collected included demographics, substance use, PrEP use, and sexual risk. Participants were recruited via sexual networking/dating applications and resided in the U.S. including Puerto Rico, were at least 13 years old, self-reported being HIV-negative, and identified as male. The sample was divided into two groups: YSMM (13–24 years of age) and adult SMM (25 years of age and up). Multinomial logistic regressions examining associations with never, current, and former PrEP use were run with all variables of interest simultaneously entered into the models. Age was positively associated with both former and current PrEP use among YSMM. Additionally, YSMM who identified as gay (vs. bisexual), lived in the Northeast, Midwest, and West (vs. South), had their own health insurance (vs. those on their parent’s), had recently been diagnosed with an STI, and had recently used a drug all had higher odds of being a current PrEP user compared to those that had never used PrEP. Among adult SMM, those who were older did not have higher odds of current PrEP use compared to those that had never used PrEP. Those who identified as queer (vs. gay), single, had their own or were on their partner’s insurance (vs. parent’s), recent condomless anal sex, recent STI diagnosis, recent drug use, and recent substance use all had higher odds of being a current PrEP user compared to those that had never used PrEP. Research is needed to address the disparities in PrEP uptake among YSMM. Interventions for PrEP access among those on their parents’ insurance may also be necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aghaizu, A., Mercey, D., Copas, A., Johnson, A. M., Hart, G., & Nardone, A. (2013). Who would use PrEP? Factors associated with intention to use among MSM in London: A community survey. Sexually Transmitted Infections,89(3), 207–211.

    Article  Google Scholar 

  • Arnold, T., Brinkley-Rubinstein, L., Chan, P. A., Perez-Brumer, A., Bologna, E. S., Beauchamps, L., … Nunn, A. (2017). Social, structural, behavioral and clinical factors influencing retention in pre-exposure prophylaxis (PrEP) care in Mississippi. PLoS ONE,12(2), e0172354. https://doi.org/10.1371/journal.pone.0172354.

    Article  PubMed  PubMed Central  Google Scholar 

  • Barash, E. A., & Golden, M. (2010). Awareness and use of HIV pre-exposure prophylaxis among attendees of a Seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care and STDs,24(11), 689–691.

    Article  Google Scholar 

  • Centers for Disease Control and Prevention. (2012). PrEP: A new tool for HIV prevention. Retrieved July 4, 2018 from http://www.cdc.gov/hiv/pdf/prevention_prep_factsheet.pdf.

  • Centers for Disease Control and Prevention. (2015). HIV prevention in the United States, new opportunities, new expectations. Retrieved July 4, 2018 from https://www.cdc.gov/hiv/pdf/policies/cdc-hiv-prevention-bluebook.pdf.

  • Centers for Disease Control and Prevention. (2017). HIV in the United States by geography. Retrieved July 4, 2018 from https://www.cdc.gov/hiv/statistics/overview/geographicdistribution.html.

  • Centers for Disease Control and Prevention. (2018a). HIV preexposure prophylaxis, by race and ethnicity: United States, 2014–2016. Retrieved July 4, 2018 from https://www.cdc.gov/mmwr/volumes/67/wr/mm6741a3.htm#T1_down.

  • Centers for Disease Control and Prevention. (2018b). HIV among gay and bisexual men. Retrieved July 4, 2018 from https://www.cdc.gov/hiv/group/msm/index.html.

  • De Wit, J., Murphy, D., Lal, L., Audsley, J., Roth, N., Moore, R., … Wright, E. (2015). Pre-exposure prophylaxis and risk compensation: Evidence of decreased condom use at three-month follow-up among predominantly gay male participants in the Viceprep Study. Sexually Transmitted Infections,91(Suppl. 2), A68.

    Google Scholar 

  • Gilmore, H. J., Liu, A., Koester, K. A., Amico, K. R., McMahan, V., Goicochea, P., … Grant, R. (2013). Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx Pre-exposure Prophylaxis Trial in San Francisco. AIDS Patient Care and STDs,27(10), 560–566.

    Article  Google Scholar 

  • Goedel, W. C., Halkitis, P. N., Greene, R. E., & Duncan, D. T. (2016). Correlates of awareness of and willingness to use pre-exposure prophylaxis (PrEP) in gay, bisexual, and other men who have sex with men who use geosocial-networking smartphone applications in New York City. AIDS and Behavior,20(7), 1435–1442.

    Article  Google Scholar 

  • Guest, G., Shattuck, D., Johnson, L., Akumatey, B., Clarke, E. E. K., Chen, P.-L., & MacQueen, K. M. (2008). Changes in sexual risk behavior among participants in a PrEP HIV prevention trial. Sexually Transmitted Diseases,35(12), 1002–1008.

    PubMed  Google Scholar 

  • Haberer, J. E., Baeten, J. M., Campbell, J., Wangisi, J., Katabira, E., Ronald, A., … Ware, N. C. (2013). Adherence to antiretroviral prophylaxis for HIV prevention: A substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Medicine,10(9), e1001511. https://doi.org/10.1371/journal.pmed.1001511.

    Article  PubMed  PubMed Central  Google Scholar 

  • Holloway, I., Dougherty, R., Gildner, J., Beougher, S. C., Pulsipher, C., Montoya, J. A., … Leibowitz, A. (2017). PrEP uptake, adherence, and discontinuation among California YMSM using geosocial networking applications. Journal of Acquired Immune Deficiency Syndromes,74(1), 15–20.

    Article  Google Scholar 

  • Holt, M., Murphy, D. A., Callander, D., Ellard, J., Rosengarten, M., Kippax, S. C., & de Wit, J. B. (2012). Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sexually Transmitted Infections,88(4), 258–263.

    Article  Google Scholar 

  • Hosek, S. G., Landovitz, R. J., Kapogiannis, B., Siberry, G. K., Rudy, B., Rutledge, B., … Zimet, G. (2017). Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States. JAMA Pediatrics,171(11), 1063–1071.

    Article  Google Scholar 

  • Khanna, A. S., Schumm, P., & Schneider, J. A. (2017). Facebook network structure and awareness of preexposure prophylaxis among young men who have sex with men. Annals of Epidemiology,27(3), 176–180.

    Article  Google Scholar 

  • King, H. L., Keller, S. B., Giancola, M. A., Rodriguez, D. A., Chau, J. J., Young, J. A., … Smith, D. M. (2014). Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study). AIDS and Behavior,18(9), 1722–1725.

    Article  Google Scholar 

  • Koester, K., Amico, R. K., Gilmore, H., Liu, A., McMahan, V., Mayer, K., … Grant, R. (2017). Risk, safety and sex among male PrEP users: Time for a new understanding. Culture, Health & Sexuality,19(12), 1301–1313.

    Article  Google Scholar 

  • Kuhns, L. M., Hotton, A. L., Schneider, J., Garofalo, R., & Fujimoto, K. (2017). Use of pre-exposure prophylaxis (PrEP) in young men who have sex with men is associated with race, sexual risk behavior and peer network size. AIDS and Behavior,21(5), 1376–1382.

    Article  Google Scholar 

  • Liu, A. Y., Vittinghoff, E., Chillag, K., Mayer, K., Thompson, M., Grohskopf, L., … O’Hara, B. (2013). Sexual risk behavior among HIV-uninfected men who have sex with men (MSM) participating in a tenofovir pre-exposure prophylaxis (PrEP) randomized trial in the United States. Journal of Acquired Immune Deficiency Syndromes,64(1), 87–94.

    Article  Google Scholar 

  • Mack, N., Odhiambo, J., Wong, C. M., & Agot, K. (2014). Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: Results of a consultation with community stakeholders. BMC Health Services Research,14(1), 231. https://doi.org/10.1186/1472-6963-14-231.

    Article  PubMed  PubMed Central  Google Scholar 

  • Marcus, J. L., Glidden, D. V., Mayer, K. H., Liu, A. Y., Buchbinder, S. P., Amico, K. R., … Pilotto, J. (2013). No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS ONE,8(12), e81997. https://doi.org/10.1371/journal.pone.0081997.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mustanski, B., Johnson, A. K., Garofalo, R., Ryan, D., & Birkett, M. (2013). Perceived likelihood of using HIV pre-exposure prophylaxis medications among young men who have sex with men. AIDS and Behavior,17(6), 2173–2179.

    Article  Google Scholar 

  • National Institute of Child Health and Human Development. (2018). Item of interest: FDA approves PrEP therapy for adolescents at risk of HIV. Retrieved July 4, 2018 from https://www.nichd.nih.gov/news/releases/051618-PrEP.

  • Newcomb, M. E., Moran, K., Feinstein, B. A., Forscher, E., & Mustanski, B. (2018). Pre-exposure prophylaxis (PrEP) use and condomless anal sex: Evidence of risk compensation in a cohort of young men who have sex with men. Journal of Acquired Immune Deficiency Syndromes,77(4), 358–364.

    Article  Google Scholar 

  • Parsons, J. T., Rendina, H. J., Lassiter, J. M., Whitfield, T. H., Starks, T. J., & Grov, C. (2017). Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States. Journal of Acquired Immune Deficiency Syndromes,74(3), 285–292.

    Article  Google Scholar 

  • Rendina, H. J., Whitfield, T. H., Grov, C., Starks, T. J., & Parsons, J. T. (2017). Distinguishing hypothetical willingness from behavioral intentions to initiate HIV pre-exposure prophylaxis (PrEP): Findings from a large cohort of gay and bisexual men in the US. Social Science and Medicine,172, 115–123.

    Article  Google Scholar 

  • Sagaon-Teyssier, L., Suzan-Monti, M., Demoulin, B., Capitant, C., Lorente, N., Préau, M., … Chas, J. (2016). Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY Trial. AIDS Care,28(Suppl. 1), 48–55.

    Article  Google Scholar 

  • San Francisco AIDS Foundation. (2018). The questions about PrEP. Retrieved July 4, 2018 from https://prepfacts.org/prep/the-questions/.

  • Smith, D. K., Toledo, L., Smith, D. J., Adams, M. A., & Rothenberg, R. (2012). Attitudes and program preferences of African–American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Education and Prevention,24(5), 408–421.

    Article  Google Scholar 

  • Sullivan, P. S., Giler, R. M., Mouhanna, F., Pembleton, E. S., Guest, J. L., Jones, J., … McCallister, S. (2018). Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017. Annals of Epidemiology,28(12), 833–840.

    Article  Google Scholar 

  • Tangmunkongvorakul, A., Chariyalertsak, S., Amico, K. R., Saokhieo, P., Wannalak, V., Sangangamsakun, T., … Grant, R. (2013). Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx Study in Chiang Mai, Thailand. AIDS Care,25(8), 961–967.

    Article  Google Scholar 

  • Taylor, S. W., Mayer, K. H., Elsesser, S. M., Mimiaga, M. J., O’Cleirigh, C., & Safren, S. A. (2014). Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP naive men. AIDS and Behavior,18(5), 871–879.

    Article  Google Scholar 

  • United States Food and Drug Administration. (2012). FDA approves first medication to reduce HIV risk. Retrieved July 4, 2018 from https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm311821.htm.

  • U.S. Department of Health and Human Services. (2017). Young adult coverage. Retrieved July 4, 2018 from https://www.hhs.gov/healthcare/about-the-aca/young-adult-coverage/index.html.

  • Volk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B. (2015). No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clinical Infectious Diseases,61(10), 1601–1603.

    Article  Google Scholar 

Download references

Acknowledgements

The UNITE study was funded by a research grant from the National Institute of Allergy and Infectious Diseases and National Institute of Child Health and Human Development (UG3-AI133674: H. Jonathon Rendina, PI). Thomas H.F. Whitfield was supported by a Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) (F31 MH116874-02). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors would like to acknowledge the contributions of the other members of the UNITE Study Team (Devin English, Steven A. John, Ali Talan, Stephen S. Jones, Juan Castiblanco, and Ruben Jimenez), our collaborators and consultants on the project (Brian Mustanski, Carlos Rodriguez-Diaz, Eli Rosenberg, and Mark Pandori) and all of the amazing staff from the Center for HIV/AIDS Educational Studies and Training. Finally, we thank all of our participants in the UNITE study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Jonathon Rendina.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Whitfield, T.H.F., Parsons, J.T. & Rendina, H.J. Rates of Pre-exposure Prophylaxis Use and Discontinuation Among a Large U.S. National Sample of Sexual Minority Men and Adolescents. Arch Sex Behav 49, 103–112 (2020). https://doi.org/10.1007/s10508-019-01602-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10508-019-01602-z

Keywords

Navigation